Marketing Manager, Oncology - Thought Leadership & Strategic Accounts (Remote)
Myriad Genetics
- Salt Lake City, UT
- Permanent
- Full-time
- Catalyst for collaboration between Myriad ONC, regional and national Key Opinion Leaders (KOLs)
- Identify, engage and foster relationships with Regional KOLs/brand advocates of top community-based surgeon and oncology-based practices identified by Marketing and in conjunction with local field intelligence on regional peer influence map.
- Identify, engage and foster relationships with key like-minded societies and organizations
- Develop regional brand advocate program to drive peer-to-peer interactions in key geographies, as identified by marketing and sales
- Assist omnichannel team with execution of content that leverages regional and national KOLs
- Partner with national accounts team to build strategy to build key relationships in strategic accounts
- Bachelor's degree or equivalent experience required
- 4-6+ years of clinical, sales, or marketing in oncology-related field required
- Ability to grow and maintain strong relationships with regional Key Opinion Leaders; Establish and maintain positive working relationships with others both internally and externally
- Ability to Navigate the Decision-Making Unit (DMU) within key target markets
- Effective communication and presentation skills
- 10-15% travel required
Please answer all questions completely. Please do not provide any information not specifically requested on this Employment Application form.About the Team: Myriad Oncology, a business unit of Myriad Genetics focuses on three products EndoPredict®, BRACAnalysis CDx® and The Myriad myRisk® Hereditary Cancer. EndoPredict® can help accurately determine an individual patient's 10-year risk of recurrence to help physicians identify which patients may consider safely forgoing chemotherapy.BRACAnalysis CDx® is an FDA-approved laboratory developed test for BRCA1 and BRCA2 intended to inform patient management related to the PARP inhibitors, Lynparza® (olaparib) and Zejula® (niraparib). The Myriad myRisk® Hereditary Cancer test is a multi-gene panel that identifies an elevated risk for eight hereditary cancers: Blending both genetic test status AND personal cancer family history, Myriad myRisk hereditary cancer panel represents the next generation of hereditary cancer risk testing.